According to Yahoo!Finance, Regulus Therapeutics (RGLS) is “…a clinical stage biopharmaceutical company, engages in the discovery and development of medicines that target microRNAs to treat a range of diseases in the United States and Europe.”
All within a bull market is all we can say about this chart.